NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NCT00749346 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
NSCLC

Interventions

DEVICE: NovoTTF-100L

Sponsor

NovoCure Ltd.